Emcure Pharmaceuticals Limited (BOM:544210)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2012	Mar 31, 2011
Pharmaceuticals	92.04B	78.96B	66.58B	59.86B	58.55B
Pharmaceuticals Growth	16.56%	18.59%	11.23%	2.23%	16.33%
Total	92.04B	78.96B	66.58B	59.86B	58.55B
Total Growth	16.56%	18.59%	11.23%	2.23%	16.33%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2012	Mar 31, 2011
India	40.27B	36.59B	32.15B	31.82B	32.05B
India Growth	10.05%	13.82%	1.04%	-0.71%	27.67%
EM	18.40B	-	-	-	-
EU	18.50B	-	-	-	-
CA	14.87B	-	-	-	-
ROW	-	14.15B	10.92B	8.87B	10.74B
ROW Growth	-	29.55%	23.06%	-17.42%	-4.85%
Europe	-	15.25B	14.24B	11.87B	8.97B
Europe Growth	-	7.16%	19.90%	32.39%	21.47%
North America	-	12.97B	9.28B	7.29B	6.79B
North America Growth	-	39.75%	27.21%	7.35%	3.60%
Total	92.04B	78.96B	66.58B	59.86B	58.55B
Total Growth	16.57%	18.59%	11.23%	2.23%	16.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error